Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding
- PMID: 8399019
- DOI: 10.1111/j.1471-0528.1993.tb14272.x
Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding
Abstract
Objective: To study fibrinolysis in the endometrium in women with normal menstruation and dysfunctional uterine bleeding (DUB).
Design: Tissue plasminogen activator activity (t-PA) and antigen (t-PAAg) and plasminogen activator inhibitor Type 1 antigen (PAI-1) were measured in homogenates of endometrium sampled between 24 and 36 h after the onset of menstruation.
Subjects: Women complaining of menorrhagia who had negative findings at clinical examination and curettage had their menstrual blood loss (MBL) measured from the third cycle after D&C. Those with MBL greater than 80 ml per cycle formed the DUB group.
Measurements: Fibrinolytic enzyme antigen levels were measured with ELISAs. Tissue plasminogen activator activity was assayed by measuring the rate of conversion of Glu-plasminogen to plasmin, using a chromogenic plasmin substrate.
Conclusions: There is a strong positive correlation between endometrial t-PA activity on the second day of menstruation and measured menstrual loss (P < 0.05). Concentrations of endometrial t-PAAg and PAI-1 antigen are higher in women with DUB compared with normal women during menstruation.
Similar articles
-
The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.Acta Obstet Gynecol Scand. 1994 Mar;73(3):274-7. doi: 10.3109/00016349409023453. Acta Obstet Gynecol Scand. 1994. PMID: 8122512
-
Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia.Am J Obstet Gynecol. 1994 Jul;171(1):178-83. doi: 10.1016/0002-9378(94)90466-9. Am J Obstet Gynecol. 1994. PMID: 8030696
-
The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia.J Thromb Haemost. 2007 Jan;5(1):133-8. doi: 10.1111/j.1538-7836.2006.02243.x. Epub 2006 Sep 28. J Thromb Haemost. 2007. PMID: 17010149 Clinical Trial.
-
Endometrial haemostasis and menstruation.Rev Endocr Metab Disord. 2012 Dec;13(4):289-99. doi: 10.1007/s11154-012-9226-4. Rev Endocr Metab Disord. 2012. PMID: 23180227 Review.
-
The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.Hum Reprod Update. 2016 Jun;22(4):497-515. doi: 10.1093/humupd/dmw004. Epub 2016 Feb 23. Hum Reprod Update. 2016. PMID: 26912000 Free PMC article. Review.
Cited by
-
The Menstrual Endometrium: From Physiology to Future Treatments.Front Reprod Health. 2022 Jan 31;3:794352. doi: 10.3389/frph.2021.794352. eCollection 2021. Front Reprod Health. 2022. PMID: 36304053 Free PMC article. Review.
-
Menstruation: science and society.Am J Obstet Gynecol. 2020 Nov;223(5):624-664. doi: 10.1016/j.ajog.2020.06.004. Epub 2020 Jul 21. Am J Obstet Gynecol. 2020. PMID: 32707266 Free PMC article. Review.
-
Biomarkers in abnormal uterine bleeding†.Biol Reprod. 2019 Dec 24;101(6):1155-1166. doi: 10.1093/biolre/ioy231. Biol Reprod. 2019. PMID: 30388215 Free PMC article. Review.
-
Cyclic processes in the uterine tubes, endometrium, myometrium, and cervix: pathways and perturbations.Mol Hum Reprod. 2023 Apr 29;29(5):gaad012. doi: 10.1093/molehr/gaad012. Mol Hum Reprod. 2023. PMID: 37225518 Free PMC article. Review.
-
Uterine bleeding: how understanding endometrial physiology underpins menstrual health.Nat Rev Endocrinol. 2022 May;18(5):290-308. doi: 10.1038/s41574-021-00629-4. Epub 2022 Feb 8. Nat Rev Endocrinol. 2022. PMID: 35136207 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous